{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T07:38:08Z","timestamp":1764401888772,"version":"build-2065373602"},"reference-count":18,"publisher":"Elsevier BV","issue":"44","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T00:00:00Z","timestamp":1633219200000},"content-version":"am","delay-in-days":367,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000005","name":"U.S. Department of Defense","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.vaccine.2020.08.061","type":"journal-article","created":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T16:42:17Z","timestamp":1599410537000},"page":"6899-6903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Immune response at 12\u201323\u00a0months following a single dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine"],"prefix":"10.1016","volume":"38","author":[{"given":"Elisabeth R.","family":"Krow-Lucal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janeen","family":"Laven","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lori","family":"Perry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brad J.","family":"Biggerstaff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara W.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewell","family":"Hollis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tabitha","family":"Woolpert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1408-6047","authenticated-orcid":false,"given":"Susan L.","family":"Hills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.08.061_b0005","doi-asserted-by":"crossref","first-page":"766","DOI":"10.2471\/BLT.10.085233","article-title":"Estimated global incidence of Japanese encephalitis: a systematic review","volume":"89","author":"Campbell","year":"2011","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2020.08.061_b0010","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.68.4.405","article-title":"Japanese encephalitis","volume":"68","author":"Solomon","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.vaccine.2020.08.061_b0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6802a1","article-title":"Japanese encephalitis vaccine: Recommendations of the Advisory Committee on Immunization Practices","volume":"68","author":"Hills","year":"2019","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.vaccine.2020.08.061_b0020","first-page":"898","article-title":"Use of Japanese encephalitis vaccine in children: Recommendations of the Advisory Committee on Immunization Practices, 2013","volume":"62","author":"Centers for Disease Control and Prevention","year":"2013","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.08.061_b0025","first-page":"664","article-title":"Update on Japanese encephalitis vaccine for children: United States, May 2011","volume":"60","author":"Centers for Disease Control and Prevention","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2020.08.061_b0030","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1016\/j.vaccine.2012.02.063","article-title":"Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine","volume":"30","author":"Woolpert","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.061_b0035","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1093\/cid\/cis542","article-title":"A single dose of Vero cell-derived Japanese encephalitis (JE) vaccine (Ixiaro) effectively boosts immunity in travelers primed with mouse brain-derived JE vaccines","volume":"55","author":"Erra","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2020.08.061_b0040","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.vaccine.2013.10.055","article-title":"Cross-protection elicited by primary and booster vaccinations against Japanese encephalitis: A two-year follow-up study","volume":"32","author":"Erra","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.061_b0045","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1128\/jcm.4.6.503-510.1976","article-title":"Serum dilution neutralization test for California group virus identification and serology","volume":"4","author":"Lindsey","year":"1976","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2020.08.061_b0050","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1128\/CVI.00095-09","article-title":"Evaluation of chimeric Japanese encephalitis and dengue viruses for use in diagnostic plaque reduction neutralization tests","volume":"16","author":"Johnson","year":"2009","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.08.061_b0055","doi-asserted-by":"crossref","first-page":"5205","DOI":"10.1016\/j.vaccine.2005.07.002","article-title":"Report on a WHO consultation on immunological endpoints for evaluation of new Japanese encephalitis vaccines, WHO, Geneva, 2\u20133 September, 2004","volume":"23","author":"Hombach","year":"2005","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.061_b0060","unstructured":"Food and Drug Administration. Package insert and patient information \u2014 IXIARO. Available at https:\/\/www.fda.gov\/BiologicsBloodVaccines\/Vaccines\/ApprovedProducts\/ucm179132.htm. Accessed January 28, 2020."},{"year":"1997","series-title":"Bootstrap Methods and Their Application","author":"Davison","key":"10.1016\/j.vaccine.2020.08.061_b0065"},{"key":"10.1016\/j.vaccine.2020.08.061_b0070","unstructured":"R Core Team. R: A language and environment for statistical computing. 2019. R Foundation for Statistical Computing, Vienna, Austria. Available at https:\/\/www.R-project.org\/. Accessed April 2, 2019."},{"key":"10.1016\/j.vaccine.2020.08.061_b0075","unstructured":"Hesterberg T. resample: Resampling Functions. R package version 0.4. 2015. Available at: https:\/\/cran.r-project.org\/web\/packages\/resample\/index.html. Accessed November 6, 2019."},{"key":"10.1016\/j.vaccine.2020.08.061_b0080","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1016\/j.vaccine.2009.05.034","article-title":"Safety and immunogenicity of concomitant vaccination with the cell-culture based Japanese encephalitis vaccine IC51 and the hepatitis vaccine HAVRIX1440 in healthy subjects \u2014 A single-blind, randomized, controlled phase 3 study","volume":"27","author":"Kaltenbock","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.08.061_b0085","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/jtm.12210","article-title":"Short-term immunogenicity and safety of an accelerated pre-exposure prophylaxis regimen with Japanese encephalitis vaccine in combination with a rabies vaccine: A phase III, multicenter, observer-blind study","volume":"22","author":"Jelinek","year":"2015","journal-title":"J Travel Med"},{"key":"10.1016\/j.vaccine.2020.08.061_b0090","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.tmaid.2014.04.011","article-title":"Co-administration of a meningococcal glycoconjugate ACWY vaccine with travel vaccines: A randomized, open-label, multi-center study","volume":"12","author":"Alberer","year":"2014","journal-title":"Travel Med Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20311130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20311130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:46:54Z","timestamp":1759402014000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20311130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":18,"journal-issue":{"issue":"44","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0264410X20311130"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.061","relation":{},"ISSN":["0264-410X"],"issn-type":[{"type":"print","value":"0264-410X"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immune response at 12\u201323\u00a0months following a single dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.08.061","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}